Related Experiment Video
Updated: Oct 25, 2025

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection
Published on: September 2, 2014
Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses
Christina F Budden1,2,3, Linden J Gearing3,4, Romina Kaiser1
1Institute of Innate Immunity University Hospital University of Bonn Bonn Germany.
Abstract:
Infectious organisms and damage of cells can activate inflammasomes, which mediate tissue inflammation and adaptive immunity. These mechanisms evolved to curb the spread of microbes and to induce repair of the damaged tissue. Chronic activation of inflammasomes, however, contributes to non-resolving inflammatory responses that lead to immuno-pathologies. Inflammasome-activated cells undergo an inflammatory cell death associated with the release of potent pro-inflammatory cytokines and poorly characterized extracellular vesicles (EVs). Since inflammasome-induced EVs could signal inflammasome pathway activation in patients with chronic inflammation and modulate bystander cell activation, we performed a systems analysis of the ribonucleic acid (RNA) content and function of two EV classes. We show that EVs released from inflammasome-activated macrophages carry a specific RNA signature and contain interferon β (IFNβ). EV-associated IFNβ induces an interferon signature in bystander cells and results in dampening of NLRP3 inflammasome responses. EVs could, therefore, serve as biomarkers for inflammasome activation and act to prevent systemic hyper-inflammatory states by restricting NLRP3 activation in bystander cells.
Insights
Extracellular vesicles (EVs) from inflammasome-activated cells carry interferon beta (IFNβ), acting as biomarkers for inflammation. These EVs dampen NLRP3 inflammasome responses, potentially preventing hyper-inflammation.
Area of Science:
- Immunology
- Cell Biology
- Molecular Medicine
Background:
- Inflammasomes mediate inflammation and immunity, crucial for microbial defense and tissue repair.
- Chronic inflammasome activation drives non-resolving inflammation and immunopathology.
- Inflammasome-activated cells release extracellular vesicles (EVs) with pro-inflammatory cytokines.
Purpose of the Study:
- To investigate the RNA content and function of EVs released from inflammasome-activated macrophages.
- To determine if EVs can serve as biomarkers for inflammasome activation.
- To explore the role of EVs in modulating bystander cell activation and inflammation.
Main Methods:
- Systems analysis of RNA content in two classes of EVs.
- Characterization of EV-associated molecules, including interferon beta (IFNβ).
- Assessing the functional impact of EVs on bystander cells and inflammasome responses.
Main Results:
- EVs from inflammasome-activated macrophages exhibit a specific RNA signature.
- These EVs contain and transfer functional interferon beta (IFNβ) to bystander cells.
- EV-associated IFNβ induces an interferon signature in bystander cells and dampens NLRP3 inflammasome activation.
Conclusions:
- Inflammasome-induced EVs can serve as biomarkers for inflammasome pathway activation.
- EV-associated IFNβ plays a regulatory role, preventing systemic hyper-inflammatory states.
- EVs may act as a negative feedback mechanism to restrict excessive inflammasome responses.
More Related Videos
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Regulation of the Unfolded Protein Response
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

